EDVA:NYSEMKT, Endovia Health Sciences Inc.
EDVA stock overview
Endovia Health Sciences Inc. (EDVA:NYSEMKT) closed at $0.160 on October 23, 2026,
up 7.17% on the day.
The stock trades 98.2% below its 52-week high of $9.04
and 19.4% above its 52-week low of $0.134.
Over the past year, it lost 92.7%.
Endovia Health Sciences Inc. is part of the Consumer Non-Durables sector.
Key figures
- Price
- $0.160
- Day change
- +7.17%
- Volume
- 1,966,113
- Average volume
- 4,501,362
- Market cap
- 1M+
- 52-week range
- $0.134 – $9.04
- 50-day average
- $0.242
- 200-day average
- $1.10
Price action over the past year
In 164 trading sessions since March 3, 2026, EDVA closed higher on 56 days (34%).
Its best day was June 3, 2026 (+70.42%) and its worst was April 23, 2026 (-34.30%).
The stock moved 10% or more in a single session 31 times.
It opened at least 5% above the previous day's high 3 times.
Recent signals
EDVA news
-
Oct 5, 2026:
Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil® for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway
-
Oct 5, 2026:
Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway
-
Sep 22, 2026:
Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil Development Amid Growing Federal Support for Botanical Drug Pathways
-
Sep 22, 2026:
Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways
-
Aug 31, 2026:
Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline
-
Aug 31, 2026:
Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil FDA Submission and Expands Development Pipeline
-
Aug 25, 2026:
Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil Veterinary Development Program
-
Aug 25, 2026:
Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program
About Endovia Health Sciences Inc.
Splash Beverage Group, Inc. (NYSE American: SBEV) is transitioning toward Endovia Health Sciences , a diversified cannabinoid-based health sciences platform focused on acquiring, developing and commercializing differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets.
Similar stocks
Find more stocks like EDVA with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.